Friday, 2 March 2012

Partnering Agreements with Bigpharma

The Partnering Agreements with Bigpharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies.

Partnering Agreements with Bigpharma provides the user with the following key benefits:
• Detailed partnering activity profiles for each of the top 50 bigpharma companies
• Over 300 charts showing a company’s dealmaking activity since 2007, allowing quick identification potential partners
• Partnering therapy focus revealed
• Partnering activity since 2007 – number of deals per year
• Full listing of partnering deals
• Activity by deal type
• Activity by industry sector
• Activity by phase of development
• Activity by technology type
• Activity by therapeutic area
• Comprehensive access to over 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available
• Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents
• Understand the key deal terms the company has agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Bigpharma Partnering Agreements Report

Published: February 2012
No. of Pages: 712
Price: US$2695   
              Request SamplePartnering Agreements with Bigpharma is intended to provide the reader with an in-depth understanding of the partnering activities of the leading fifty biopharma companies worldwide, enabling the effective assessment and selection of partners of choice, based on the latest knowledge of a company’s partnering.

Partnering Agreements with Bigpharma includes:
• Detailed company profiles for each of the top 50 bigpharma companies, including:
• Partnering interests and indications
• Partnering activity since 2007
• Partner companies since 2007
• Partnering activity since 2007 by:
• Partner company
• Deal type
• Industry sector
• Stage of development
• Technology type
• Therapy area
• Over 300 charts showing the dealmaking activity of each company since 2007
• The tools to enable effective and efficient preparation for partnering negotiation with bigpharma
• 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available
• The leading M&A and partnering deals by value 2007-2012

Major points covered in Table of Contents of this report include:
• Executive Summary
• Chapter 1 – Introduction
• Chapter 2 – Bigpharma top 50 dealmaking activity
• Chapter 3 – Top bigpharma deals by value
• Chapter 4 – Submitting Opportunities to Bigpharma
• Chapter 5 – Forthcoming bigpharma partnering events
• Chapter 6 – Bigpharma Company Profiles
• Chapter 7 – Resources
• Appendices
• List of Figures

Explore Reports related to Biotechnology @

No comments:

Post a Comment